The GLP-1 receptor agonist, such as liraglutide, promotes the synthesis and secretion of insulin, and inhibits appetite, gastric emptying and food intake to control blood glucose level in diabetes (68, 69). The gene discussed is INS; the disease is diabetes mellitus.